RBC Capital Starts Endocyte (ECYT) at Outperform
Tweet
Share
E-mailGet Alerts ECYT Hot Sheet
Price: $23.99 --0%
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 2
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 2
Join SI Premium – FREE
RBC Capital initiates coverage on Endocyte (NASDAQ: ECYT) with an Outperform. PT $14.
For more ratings news on Endocyte click here and for the rating history of Endocyte click here.
Shares of Endocyte closed at $7.94 yesterday.
For more ratings news on Endocyte click here and for the rating history of Endocyte click here.
Shares of Endocyte closed at $7.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Starts Natera (NTRA) at Outperform
- Bernstein SocGen Group Starts Monster Beverage (MNST) at Market Perform
- Macquarie Starts Adani Power Limited (ADANI:IN) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
